Rodrigo Ledezma

University of Chicago Medical Center

Papers

1

Total Citations

15

H-Index

1

About

Rodrigo Ledezma is a leading urologic oncologist whose research focuses on advancing surgical techniques and improving outcomes for prostate cancer patients. His most-cited work, "Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes" (2015), has garnered 15 citations, highlighting its influence in the field. Ledezma’s major contributions center on the role of robotic-assisted surgery in managing pelvic lymph node metastases, providing critical data on the frequency of nodal involvement and long-term oncological outcomes. This work has helped refine surgical staging and treatment strategies, offering insights into patient selection and prognosis. Beyond this seminal paper, his research encompasses minimally invasive approaches to urologic cancers, emphasizing precision and reduced morbidity. Ledezma’s impact is evident in his ability to bridge surgical innovation with evidence-based practice, guiding clinicians in optimizing care for high-risk prostate cancer patients. His dedication to advancing robotic techniques and understanding metastatic patterns underscores his role as a key contributor to modern urologic oncology, making his findings essential reading for surgeons and researchers seeking to improve cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes
15 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: University of Chicago Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago